These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 27563077)

  • 21. Learning new tricks from an old dog: recent findings in familial hypercholesterolemia.
    Cullen P; Lorkowski S
    Curr Opin Lipidol; 2003 Dec; 14(6):635-7. PubMed ID: 14624141
    [No Abstract]   [Full Text] [Related]  

  • 22. Autosomal recessive hypercholesterolaemia: normalization of plasma LDL cholesterol by ezetimibe in combination with statin treatment.
    Lind S; Olsson AG; Eriksson M; Rudling M; Eggertsen G; Angelin B
    J Intern Med; 2004 Nov; 256(5):406-12. PubMed ID: 15485476
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Fluvastatin].
    Teramoto T
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():587-91. PubMed ID: 11347136
    [No Abstract]   [Full Text] [Related]  

  • 24. [The lipid patient. Case 3. Polygene hypercholesterolemia].
    Richter WO
    Fortschr Med; 1997 Dec; 115(34):38-40. PubMed ID: 9465474
    [No Abstract]   [Full Text] [Related]  

  • 25. Efficacy and safety of long-term ezetimibe/simvastatin treatment in patients with familial hypercholesterolemia.
    Katsiki N; Athyros VG; Karagiannis A; Mikhailidis DP
    Int Angiol; 2011 Jun; 30(3):295; author reply 296. PubMed ID: 21617615
    [No Abstract]   [Full Text] [Related]  

  • 26. Screening and follow-up of infants with dyslipoproteinemia.
    Roseneu M; Van Biervliet JP
    Prog Clin Biol Res; 1985; 188():79-86. PubMed ID: 3933016
    [No Abstract]   [Full Text] [Related]  

  • 27. Lipid Screening in Children and Adolescents.
    Urbina EM; de Ferranti SD
    JAMA; 2016 Aug; 316(6):589-91. PubMed ID: 27532913
    [No Abstract]   [Full Text] [Related]  

  • 28. Familial hypercholesterolemia--we must act boldly.
    Moodie D
    Congenit Heart Dis; 2014; 9(4):273-4. PubMed ID: 25099345
    [No Abstract]   [Full Text] [Related]  

  • 29. NHLBI Integrated Guidelines on Cardiovascular Disease Risk Reduction: can we clarify the controversy about cholesterol screening and treatment in childhood?
    de Ferranti SD; Daniels SR; Gillman M; Vernacchio L; Plutzky J; Baker AL
    Clin Chem; 2012 Dec; 58(12):1626-30. PubMed ID: 22730451
    [No Abstract]   [Full Text] [Related]  

  • 30. [New strategies in treatment of severe hypercholesterolemia in coronary patients: HMG-CoA reductase inhibitors and H.E.L.P.-LDL apheresis].
    Thiery J; Seidel D
    Versicherungsmedizin; 1992 Dec; 44(6):186-92. PubMed ID: 1475888
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness of genetic cascade screening for familial hypercholesterolaemia using a centrally co-ordinated clinical service: an Australian experience.
    Bell DA; Pang J; Burrows S; Bates TR; van Bockxmeer FM; Hooper AJ; O'Leary P; Burnett JR; Watts GF
    Atherosclerosis; 2015 Mar; 239(1):93-100. PubMed ID: 25585028
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A boy with autosomal recessive hypercholesterolaemia.
    Rodenburg J; Wiegman A; Vissers MN; Kastelein JJ; Stalenhoef AF
    Neth J Med; 2004 Mar; 62(3):89-93. PubMed ID: 15209474
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In brief: Zetia and Vytorin: the ENHANCE study.
    Med Lett Drugs Ther; 2008 Jan; 50(1278):5. PubMed ID: 18219263
    [No Abstract]   [Full Text] [Related]  

  • 34. A pragmatic view of the new cholesterol treatment guidelines.
    Keaney JF; Curfman GD; Jarcho JA
    N Engl J Med; 2014 Jan; 370(3):275-8. PubMed ID: 24283199
    [No Abstract]   [Full Text] [Related]  

  • 35. Universal screening and drug treatment of dyslipidemia in children and adolescents.
    Psaty BM; Rivara FP
    JAMA; 2012 Jan; 307(3):257-8. PubMed ID: 22174386
    [No Abstract]   [Full Text] [Related]  

  • 36. First case report of familial hypercholesterolemia in an Omani family due to novel mutation in the low-density lipoprotein receptor gene.
    Al-Hinai AT; Al-Abri A; Al-Dhuhli H; Al-Waili K; Al-Sabti H; Al-Yaarubi S; Al-Hashmi K; Banerjee Y; Al-Zakwani I; Al-Rasadi K
    Angiology; 2013 May; 64(4):287-92. PubMed ID: 23162007
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and safety of coadministration of rosuvastatin, ezetimibe, and colestimide in heterozygous familial hypercholesterolemia.
    Kawashiri MA; Nohara A; Noguchi T; Tada H; Nakanishi C; Mori M; Konno T; Hayashi K; Fujino N; Inazu A; Kobayashi J; Mabuchi H; Yamagishi M
    Am J Cardiol; 2012 Feb; 109(3):364-9. PubMed ID: 22112743
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of PCSK9: is this the way forward for managing residual risk?
    Chowdhury SR; Rees A
    Curr Opin Lipidol; 2012 Oct; 23(5):509-10. PubMed ID: 22964999
    [No Abstract]   [Full Text] [Related]  

  • 39. Genetic diagnosis of familial hypercholesterolemia in a South European outbreed population: influence of low-density lipoprotein (LDL) receptor gene mutations on treatment response to simvastatin in total, LDL, and high-density lipoprotein cholesterol.
    Chaves FJ; Real JT; García-García AB; Civera M; Armengod ME; Ascaso JF; Carmena R
    J Clin Endocrinol Metab; 2001 Oct; 86(10):4926-32. PubMed ID: 11600564
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heterozygous familial hypercholesterolemia case study.
    Friedrich DA
    J Am Acad Nurse Pract; 2010 Oct; 22(10):523-6. PubMed ID: 21040085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.